Disclaimer: All compounds referenced on this site are sold for in vitro research and laboratory use only. They are not intended for human consumption, medical diagnosis, or treatment. Always follow your institution’s safety and handling protocols.

GHK-Cu is one of the most extensively studied copper peptides in the research space—and one of the most misunderstood. This GHK-Cu research guide cuts through the noise with a direct, evidence-based look at what the compound does, how it works at the molecular level, and how researchers structure their protocols for results-driven outcomes.

From tissue models to dermal research, ghk cu copper peptide continues to generate compelling data across multiple domains. Here’s what the science actually shows.

What Is GHK-Cu? The Copper Peptide Explained

GHK-Cu (Glycyl-L-Histidyl-L-Lysine–Copper) is a naturally occurring tripeptide that binds copper ions with high affinity. First isolated from human plasma in the 1970s, its concentration in the body declines significantly with age—dropping roughly 60% from age 20 to 60.

The tripeptide sequence (Gly-His-Lys) forms a stable complex with Cu²⁺ ions, and this copper-binding capacity is central to nearly every biological effect observed in research. Without the copper ion, the naked GHK peptide shows dramatically reduced activity in most assessed endpoints.

Key characteristics:

  • Molecular weight: ~401.9 g/mol (GHK-Cu complex)
  • Appearance: Blue lyophilized powder (copper gives it the characteristic color)
  • Solubility: Water-soluble; reconstitutes readily with bacteriostatic water
  • Stability: Stable in solution at 2–8°C for 2–4 weeks post-reconstitution

Shop GHK-Cu: Available in 50mg and 100mg research-grade vials.

GHK-Cu Mechanisms of Action: What the Research Shows

The ghk cu copper peptide exerts its effects through several well-documented mechanisms:

1. Copper Delivery and Enzyme Activation

Copper is an essential cofactor for multiple enzymes critical to tissue remodeling:

  • Lysyl oxidase — Cross-links collagen and elastin fibers
  • Superoxide dismutase (SOD) — Potent antioxidant defense
  • Tyrosinase — Pigmentation regulation

GHK-Cu delivers copper directly to cells more efficiently than ionic copper salts, which have poor bioavailability in tissue models.

2. Gene Expression Modulation

Research by Kang et al. demonstrated that GHK-Cu influences the expression of hundreds of genes, including upregulation of:

  • Matrix metalloproteinase inhibitors (anti-breakdown signals)
  • Vascular endothelial growth factor (VEGF)
  • Fibroblast growth factors
  • Anti-inflammatory cytokines

Simultaneously, it downregulates pro-inflammatory markers and matrix-degrading enzymes. This dual action—promoting building while inhibiting breakdown—is what makes the compound so compelling in ghk-cu skin research.

3. Stimulation of Dermal Matrix Components

In vitro and animal models consistently show GHK-Cu increases production of:

  • Collagen Type I and III — Primary structural proteins in connective tissue
  • Elastin — Provides recoil and flexibility
  • Decorin — Small leucine-rich proteoglycan involved in collagen organization
  • Glycosaminoglycans (GAGs) — Hydration and structural support

GHK-Cu Skin Research: The Primary Application Domain

Skin and tissue models represent the largest body of published GHK-Cu research. Key findings:

| Endpoint | Research Finding | Significance |

|—|—|—|

| Collagen I synthesis | Increased 2–3x in fibroblast models | Primary structural protein upregulation |

| Elastin production | Significant increase vs. controls | Improved tissue elasticity markers |

| SOD activity | Enhanced antioxidant capacity | Free radical defense |

| Wound closure rate | Accelerated in animal models | Tissue repair support |

| Inflammatory markers | Reduced TNF-α, IL-1β | Anti-inflammatory profile |

| MMP inhibition | Decreased MMP-1, MMP-2 | Anti-degradation effect |

The dual signaling—build more matrix, break down less of it—is the defining characteristic of ghk-cu skin research outcomes. Few other research compounds demonstrate this level of coordinated gene expression modulation in tissue models.

For researchers building multi-compound stacks, GHK-Cu pairs well with systemic recovery compounds. See the Peptide Stacks & Protocols Guide for stacking frameworks.

GHK-Cu Dosing Protocols for Research

Dosing frameworks vary by research model and endpoint. The following represents common protocol structures observed in published literature and research practice:

Standard Dosing Framework

| Parameter | Standard Range |

|—|—|

| Concentration (topical models) | 0.1–2.0% solution |

| Concentration (in vitro) | 10–100 μM in culture |

| Research-grade vial dosing | 2.5–5mg per administration |

| Frequency | Once to twice daily |

| Protocol duration | 4–12 weeks typical |

GHK-Cu Reconstitution

Reconstitute GHK-Cu lyophilized powder with bacteriostatic water:

  • 50mg vial + 5mL bac water = 10 mg/mL concentration
  • 100mg vial + 10mL bac water = 10 mg/mL concentration

Adjust diluent volume based on your target dose and syringe precision. For detailed reconstitution procedures, refer to the Peptide Stacks & Protocols Guide.

Stacking Considerations

GHK-Cu stacks effectively with:

  • NAD+ — Cellular energy and repair pathways (see NAD+ Research Guide)
  • BPC-157 — Tissue repair via different signaling mechanisms
  • TB-500 — Actin-binding and cellular migration pathways

For full stacking protocols, see the Best Peptide Stacks Research guide.

GHK-Cu vs. Other Skin Research Peptides

How does GHK-Cu compare to other compounds in the skin research space?

| Compound | Primary Mechanism | Collagen Signal | Anti-Inflammatory | Antioxidant |

|—|—|—|—|—|

| GHK-Cu | Copper delivery + gene modulation | Strong ↑ | Strong ↓ | Strong (SOD) |

| Matrixyl (Pal-KTTKS) | Collagen transcription signal | Moderate ↑ | Minimal | Minimal |

| Argireline (Acetyl Hexapeptide-8) | SNARE complex inhibition | None | None | None |

| Epitalon | Telomerase activation | Indirect | Mild | Mild |

| Copper peptides (other) | Varies by sequence | Moderate ↑ | Moderate ↓ | Moderate |

GHK-Cu’s breadth of activity—stimulating synthesis, inhibiting degradation, reducing inflammation, and boosting antioxidant capacity simultaneously—sets it apart from single-mechanism compounds. This makes it a cornerstone compound in copper peptide research protocols.

GHK-Cu 50mg vs 100mg: Choosing the Right Vial Size

| Factor | 50mg Vial | 100mg Vial |

|—|—|—|

| Total compound | 50mg | 100mg |

| Best for | Short protocols, new researchers | Extended protocols, stacking |

| Reconstitution options | More concentrated or standard | Flexible multi-vial splitting |

| Cost per mg | Higher | Lower (economies of scale) |

| Shelf life (lyophilized) | Same | Same |

If you’re running a 4–6 week protocol at 5mg/day, a 100mg vial covers your needs. For shorter pilot studies or dose-finding protocols, start with the 50mg vial.

Shop: GHK-Cu 50mg | GHK-Cu 100mg

Frequently Asked Questions

What does GHK-Cu stand for?

GHK-Cu is the abbreviation for Glycyl-L-Histidyl-L-Lysine bound to a copper (Cu²⁺) ion. The GHK tripeptide sequence naturally occurs in human plasma and has high affinity for copper. The copper-bound form is the biologically active complex used in research.

Why is GHK-Cu powder blue?

The blue color comes directly from the copper ion in the complex. Copper(II) ions produce characteristic blue-green coloration. Authentic GHK-Cu should appear blue when lyophilized. A white or off-white powder labeled as GHK-Cu may indicate the copper-free (GHK) form, which has significantly different research properties.

How should reconstituted GHK-Cu be stored?

Store at 2–8°C (standard refrigerator temperature) after reconstitution with bacteriostatic water. Use within 2–4 weeks. Protect from light—prolonged UV exposure can degrade the peptide complex. Do not freeze reconstituted GHK-Cu, as freeze-thaw cycles can damage the copper-peptide complex.

Can GHK-Cu be used in a peptide stack?

Yes. GHK-Cu is commonly stacked with NAD+, BPC-157, and TB-500 in research protocols targeting tissue repair and cellular recovery. Each compound operates through distinct mechanisms, creating complementary signaling effects. See the Best Peptide Stacks Research guide for specific protocol structures.

Is GHK-Cu the same as other copper peptides?

No. GHK-Cu is a specific tripeptide-copper complex with extensive published research. Other copper peptides exist (e.g., AHK-Cu, Ala-His-Lys-Cu), but they have different amino acid sequences, different copper-binding affinities, and different research profiles. GHK-Cu has the largest body of supporting literature by a significant margin.

What concentration should I use for GHK-Cu in topical research models?

Published research most commonly uses concentrations between 0.1% and 2.0% GHK-Cu solution for topical application models. The specific concentration depends on your endpoint measures and model system. Start at the lower end and titrate based on observed results.

Related Guides

Shop GHK-Cu Research Compounds

  • GHK-Cu 50mg — Ideal for short-cycle and pilot research protocols
  • GHK-Cu 100mg — Extended protocols and stacking research

All products sold by BioPharma.cc are intended for in vitro research and laboratory use only. These compounds are not intended for human consumption, medical diagnosis, or therapeutic use. Research protocols should be conducted in accordance with applicable institutional and regulatory guidelines.